VB

VBI Vaccines

- NASDAQ:VBIV
Last Updated 2024-04-23

LinkedIn Profile

Access VBI Vaccines historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:vbiv 1484859 Apr 21st, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 21st, 2024 03:25AM Apr 21st, 2024 03:25AM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 20th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 20th, 2024 12:20AM Apr 20th, 2024 05:47PM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 19th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 19th, 2024 04:48AM Apr 19th, 2024 04:48AM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 18th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 18th, 2024 01:26AM Apr 18th, 2024 07:07PM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 17th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 17th, 2024 04:24AM Apr 17th, 2024 03:34PM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 16th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 16th, 2024 12:10AM Apr 16th, 2024 11:50AM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 15th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 15th, 2024 12:03AM Apr 15th, 2024 05:31PM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 14th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 13th, 2024 11:51PM Apr 14th, 2024 11:49AM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 13th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 12th, 2024 11:42PM Apr 13th, 2024 12:16PM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology
nasdaq:vbiv 1484859 Apr 12th, 2024 12:00AM VBI Vaccines Inc. 4.7K 79.00 Open Apr 11th, 2024 11:50PM Apr 12th, 2024 09:12AM VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. To learn more, visit: www.vbivaccines.com News and Insights: www.vbivaccines.com/news-and-resources/ Investors: www.vbivaccines.com/investors/ Job Opportunities: www.vbivaccines.com/careers/ Open Vaccine Development, Enveloped Virus Like Particles ("eVLP"​), Biotechnology, Infectious Disease, and Immuno-oncology Open 160 Second Street Cambridge MA US 02142 VBI Vaccines Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.